newsfilter
← Latest News
ACCESS Newswire·

Pieris Pharmaceuticals Reports First Quarter 2023 Financial Results and Business Updates

COMPANY TO HOST AN INVESTOR CONFERENCE CALL TODAY, WEDNESDAY, MAY 10, 2023, AT 8:00 AM EDTEnrollment for elarekibep Phase 2a study for asthma continues to progress with topline clinical data anticipated